Radetsky M, Wheeler R C, Roe M H, Todd J K
Pediatr Infect Dis. 1985 May-Jun;4(3):274-81. doi: 10.1097/00006454-198505000-00014.
The role of rapid diagnostic tests for Group A streptococcal disease has not been firmly established. High quality data concerning these rapid streptococcal tests are not available; current information does not allow for direct test comparisons to be made; the superiority of rapid diagnostic technology over traditional throat cultures has not been proved. Subgroups which might benefit from this technology could include those who (1) are severely ill, (2) have been excluded from school or day care because of a streptococcal infection, (3) have a history of rheumatic fever and are not taking antimicrobial prophylaxis or (4) live in a confined residential setting. Each available test kit has a mixture of performance features, allowing for individual choices based on office and practice needs. Product technology is expected to change rapidly. Reassessment of any current decision may well lead to a different conclusion in 6 to 12 months.
A群链球菌疾病快速诊断检测的作用尚未得到明确确立。目前尚无关于这些快速链球菌检测的高质量数据；现有信息无法进行直接的检测比较；快速诊断技术相对于传统咽拭子培养的优越性尚未得到证实。可能从该技术中受益的亚组人群包括：（1）病情严重者；（2）因链球菌感染而被学校或日托机构排除在外者；（3）有风湿热病史且未接受抗菌药物预防者；（4）居住在封闭居住环境中的人群。每种现有的检测试剂盒都有不同的性能特点，可根据诊所和实际需求进行个性化选择。产品技术预计将迅速变化。对当前任何决策的重新评估很可能在6至12个月后得出不同结论。
